ADCT: ADC Therapeutics SA Stock

by  •  • Comments Off on ADCT: ADC Therapeutics SA Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 306.46
Enterprise Value ($M) 551.38
Book Value ($M) -238.22
Book Value / Share -2.40
Price / Book -1.28
NCAV ($M) -252.77
NCAV / Share n/a
Price / NCAV -1.21

Profitability (mra)
Return on Invested Capital (ROIC) -0.71
Return on Assets (ROA) -0.49
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 4.16
Current Ratio 4.46

Balance Sheet (mrq) ($M)
Current Assets 257.99
Assets 272.54
Liabilities 510.76
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 70.84
Operating Income -130.65
Net Income -157.85

Cash Flow Statement (mra) ($M)
Cash From Operations -123.83
Cash from Investing -0.87
Cash from Financing 97.05

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-19 13G/A Hpwh Th Ag 9.61 14.45
04-24 13G/A BlackRock, Inc. 5.00 -1.97
02-14 13G Orbimed Advisors Llc 3.60
11-14 13G/A Redmile Group, LLC 16.20 2.22
11-13 13G/A Prosight Management, LP 9.96 48.75
2024-05-03 13G Oaktree Capital Group Holdings GP, LLC 5.19

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 234,544 881,112 26.62
2025-05-29 178,597 688,305 25.95
2025-05-28 279,331 1,106,093 25.25
2025-05-27 170,899 673,349 25.38

(click for more detail)

Similar Companies
ABBV – AbbVie Inc. ABT – Abbott Laboratories
ANRO – Alto Neuroscience, Inc. ANVS – Annovis Bio, Inc.


Financial data and stock pages provided by
Fintel.io